HCID 67080710, compound → HCID 67080752, compound
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][C:12](=[O:15])[N:11](OCC2C=CC=CC=2)[CH2:10][C@H:9]1[CH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2]>CO>[C:1]([O:5][C:6]([N:8]1[CH2:14][CH2:13][C:12](=[O:15])[NH:11][CH2:10][C@H:9]1[CH2:24][C:25]1[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=1)=[O:7])([CH3:4])([CH3:2])[CH3:3]Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 70 °C
Procedure
(R)-2-Benzyl-4-benzyloxy-5-oxo-[1,4]diazepane-1-carboxylic acid tert-butyl ester (795 mg, 1.94 mmol) was dissolved in methanol (21 ml) and stirred for 16 h at 70° C. under a hydrogen pressure of 8 bar. After cooling insoluble material was removed by filtration and the filtrate concentrated, to afford the title compound (486 mg, 82%). White foam, MS (ISP)=305.3 (M+H)+.
Workup
- temperatureAfter cooling insoluble material
- customwas removed by filtration
- concentrationthe filtrate concentrated
Sources & evidence
- ORD record
- ord-b1c7ecef3340401fa6ba499649a58781
- Source dataset
- uspto-grants-2011_12
- Patent number
- US08071586B2
Reaction notes
Loading…